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Abstract
Background: Quality end-of-life care has emerged as an important concept in industrialized
countries.
Discussion: We argue quality end-of-life care should be seen as a global public health and health
systems problem. It is a global problem because 85 % of the 56 million deaths worldwide that occur
annually are in developing countries. It is a public health problem because of the number of people
it affects, directly and indirectly, in terms of the well being of loved ones, and the large-scale,
population based nature of some possible interventions. It is a health systems problem because one
of its main features is the need for better information on quality end-of-life care. We examine the
context of end-of-life care, including the epidemiology of death and cross-cultural considerations.
Although there are examples of success, we could not identify systematic data on capacity for
delivering quality end-of-life care in developing countries. We also address a possible objection to
improving end-of-life care in developing countries; many deaths are preventable and reduction of
avoidable deaths should be the focus of attention.
Conclusions: We make three recommendations: (1) reinforce the recasting of quality end-of-life
care as a global public health and health systems problem; (2) strengthen capacity to deliver quality
end-of-life care; and (3) develop improved strategies to acquire information about the quality of
end-of-life care.
Background
Each year 56 million people die in the world [1], 85% of
these in developing countries [2]. Yet little is known about
the quality of end-of-life care in developing countries.
This article aims to explore this problem from a global
perspective and to define why it is a major global public
health and health system concern.
Modern research in end-of-life care can be seen as passing
through three phases. In the first phase the focus was at
the clinical level. An example of important research at this
level is the WHO pain treatment ladder [3]. In the second
phase the focus was at the organizational level. Early work
centred on the organization of special units or services to
deliver palliative care, as pioneered by Dame Cicely Saun-
ders. More recently, the Boston-based Institute for Health
Care Improvement [4], has focused on the application of
rapid-cycle change quality improvement strategies to the
problem of end-of-life care. The third phase, which has yet
to mature, is a focus on quality end-of-life care as a public
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health and health systems problem, especially at the glo-
bal level. This phase is the focus of the present paper.
In many Western countries a deeper recognition for the
need to improve end-of-life care is gradually emerging. It
has been argued that technological advances in medicine
have obscured the need for human compassion for the dy-
ing and their loved ones. There is also a growing public
demand for a more holistic, integrated approach toward
health, illness, death and dying. Furthermore, published
literature reveals evidence that the quality of end-of-life
care is often unsatisfactory for both patients and families.
For example, in the United States Lynn et al. [5] found
that four in 10 dying patients had severe pain most of the
time. Ahronheim et al. [6] found that 47% of incurably ill
patients with advanced dementia and metastatic cancer
received non-palliative treatments. Solomon et al. [7]
found that 78% of health care professionals surveyed re-
ported that they sometimes felt the treatments they of-
fered patients were overly burdensome. Hanson et al. [8]
found that bereaved family members felt that communi-
cation concerning end-of-life care issues was poor. And,
commenting on end-of-life care in general, Berwick con-
tends, "evidence is mounting that the excellence of the sta-
tus quo is a sentimental illusion" [9].
To address the need for improved quality end-of-life care,
several major initiatives have been launched. The Institute
for Health Care Improvement (mentioned above) has
held a quality collaborative on end-of-life care. The Open
Society Institute's Project on Death in America aims to un-
derstand and transform the culture and experience of dy-
ing and bereavement [10]. The Last Acts Campaign aims
to bring death related issues out in the open and help in-
dividuals and organizations pursue better ways to care for
the dying [11]. The American Medical Association, with a
grant from the Robert Wood Johnson Foundation,
launched a program called Education for Physicians on
End-of-Life Care project [12] whose goal is to educate all
physicians on the clinical competencies required to pro-
vide quality end-of-life care. The Ian Anderson Program
on Quality End-of-Life Care is an extensive five-year initi-
ative designed to improve end-of-life care at a health sys-
tems level throughout Canada [13]. There has been a
good deal of development and research in the United
Kingdom, as documented by the UK National Council on
Hospice and Specialist Palliative Care Services [14]. The
European Association for Palliative Care [15], a non-gov-
ernmental organization recognized by the Council of Eu-
rope, coordinates research, education, and networking
across Europe. The International Association for Hospice
and Palliative Care is helping developing countries build
programs that adapt to local cultures and realities [16].
A historical recounting would be incomplete without em-
phasizing the role of the World Health Organization
[17,18]. As Kathy Foley, a leading figure in this field,
writes in her review of our paper, "...[i]n developing its
monograph on palliative care and cancer and the develop-
ment of National Cancer Control Programs argued strong-
ly for the need to address quality end-of-life care using the
term palliative care as a public health policy issue. In ad-
vocating for governments to adopt policies for cancer care,
the WHO argued that any national cancer control pro-
gram, particularly in resource poor settings should have
four major components: prevention, early diagnosis,
treatment and palliative care" [19]. Moreover, as Nigel
Sykes, Head of Medicine at St. Christopher's Hospice
wrote in response to an earlier editorial we published on
this topic in the British Medical Journal [20], "the World
Health Organisation produced pioneering guidance in
control of pain and other symptoms at the end-of-life
[21]. In conjunction with the International Narcotics
Control Board the WHO has long pressed for greater avail-
ability of morphine [22], often against the prejudice and
inadequate knowledge of local medical groups" [23].
However, to our knowledge, no initiative has advocated
that quality end-of-life care should be viewed as a global
public health and health systems problem, and made rec-
ommendations flowing from this perspective.
In this paper, our main point is that quality end-of-life
care is appropriately viewed as a global public health and
health systems problem, and that this leads to recommen-
dations on capacity strengthening and information strate-
gies related to quality end-of-life care. We begin by
addressing the question, what is quality end-of-life care?
Then, we argue why it is a public health and health sys-
tems problem. Next, we examine important contextual as-
pects relevant to improving end-of-life care: the
epidemiology of deaths, cross-cultural considerations,
and existing capacity in developing countries in relation
to end-of-life care. Then, we confront the difficult philo-
sophical problem of whether it is justifiable to emphasize
quality end-of-life care when so many other aspects of
health care, especially in developing countries, merit im-
provement. Finally, we turn to our recommendations for
improving the quality of end-of-life care at a global level.
What is quality end-of-life care?
One of the most useful developments in the field was the
emerging focus during the 1990s on quality end-of-life
care. Before this, there had been many "pieces of the puz-
zle," such as pain control and advance directives, that had
not been brought together into an integrated focus. As a
matter of terminology, we use the term end-of-life care to
reflect this integrated concept, rather than the term pallia-
tive care, which conjures up images of service provision.
However, a sophisticated understanding of palliative careBMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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recognizes that specialists should not treat all patients but
rather treat patients whose distress cannot be controlled
by the primary physician or nurse, teach primary care
groups how to deliver end-of-life care, and conduct re-
search on end-of-life care [24]. Therefore, the terms palli-
ative care and end-of-life care are complementary. We
have not found the definitional battles between propo-
nents of these two terms enlightening, and will not pursue
these here.
But what does quality end-of-life care mean? Initial at-
tempts to address this question were based on expert as-
sessment. In 1997 the Institute of Medicine report on
"Approaching Death" identified six elements of quality
end-of-life care [25]:
· Overall quality of life
· Physical well-being and functioning
· Psychosocial well-being and functioning
· Spiritual well-being
· Patient perception of care
· Family well-being and perceptions.
The problem with this expert approach is that the aspects
of quality end-of-life care identified by expert clinicians
may not be the same as those identified by patients them-
selves. In 1999, we published a report outlining five as-
pects of end-of-life care from the patients' perspective:
receiving adequate pain and symptom management,
avoiding inappropriate prolongation of dying, achieving a
sense of control, relieving the burden on loved ones, and
strengthening relationships with loved ones [26]. This
work was built upon by Tulsky and colleagues [27], who,
through surveys of dying patients, doctors, and other
health care providers, further elaborated and elucidated
the differences and similarities in the perspectives of each
of these groups. They concluded that, "Although pain and
symptom management, communication with one's physi-
cian, preparation for death, and the opportunity to
achieve a sense of completion are important to most, oth-
er factors important to quality at the end-of-life differ by
role and by individual. Efforts to evaluate and improve
patients' and families' experiences at the end-of-life must
account for diverse perceptions."
It is important to note that this patient-focussed research
has been conducted in developed countries. It surely
omits important elements of quality end-of-life care from
a developing country perspective such as planning for or-
phan care (by 2010 there will be over 25 million orphans
because of AIDS [28]) and inheritance of land; these is-
sues may be particularly important for women.
Once defined, key elements of quality end-of-life care will
need to be measured. Although measures are available,
they tend to be focussed on the quality of care of those in
hospice, or have undue respondent burden [29]. The de-
velopment of measures for quality end-of-life care, includ-
ing those appropriate to the developing country context,
will be an important focus of future research.
This discussion of quality end-of-life care highlights that
the problem of quality end-of-life care is, among other
things, a problem of information. A fundamental barrier
to improving quality of care at the end-of-life is the lack of
information about the current state of end-of-life care
among populations. This population-based thinking
leads to the question of why quality end-of-life care
should be seen as a global public health problem.
Discussion
Why is quality end-of-life care a global public health prob-
lem?
As noted, there are 56 million deaths per year in the
world, 85 % of which are in developing countries. One
can assume that each death also affects five other people
in terms of informal care-giving and grieving relatives and
friends — a very modest estimate, particularly in the de-
veloping world. The total number of people therefore af-
fected each year in the world by end-of-life care is about
300 million people, about 5 % of the world's population
[30]. This makes quality end-of-life care a global public
health problem on the grounds of numbers of people in-
volved.
To put this problem in perspective, there are 36 million
people living with HIV, 8 million people become sick
with TB annually, resulting in 2 million deaths [31] and
300–500 million cases of malaria result in 1.5–2.7 mil-
lion deaths [32]. Admittedly, we do not conceptualize
quality end-of-life care as a public health problem in the
same way we conceptualize HIV, malaria and TB as public
health problems. But this difference may have more to do
with the social construction of these problems rather than
any intrinsic difference between quality end-of-life care
and these other problems. Like HIV, malaria, and TB,
quality end-of-life care threatens the health and well being
of a large population of people. The fact that we do not
traditionally view end-of-life care as a public health prob-
lem is perhaps more a symptom of Western death-deny-
ing culture than any intrinsic difference between quality
end-of-life care and these other global public health prob-
lems.BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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In addition to the sheer numbers, quality end-of-life care
is a global public health problem because of the nature of
the interventions that could be used to improve the prob-
lem. Improving end-of-life care will require improve-
ments in health systems as discussed below. However,
other needed interventions are more in the realm of pub-
lic health, such as large-scale educational programs for
public health workers and for the public, population-
based strategies to destigmatize death and mainstream it
into health systems, and changes in social policies in rela-
tion to, for example, orphan care.
Finally, improvement in quality end-of-life care will re-
quire health research. It is ironic therefore that of the
thousands of papers published on end-of-life care in the
last decade, only a few have addressed end-of-life care in
developing countries. This is perhaps nothing more than
another manifestation of the 90/10 gap — that 90% of
medical research is undertaken on those diseases that
cause 10% of the global burden of disease [33]. The same
gap that affects health research more generally also affects
research and practice at the end-of-life. In the sense that
global health research is a crucial element of global health
and development, quality end-of-life care is also a global
public health problem.
Why is quality end-of-life care a global health system prob-
lem?
End-of-life care is a health systems problem in the sense
that — at least in some countries — the majority of deaths
occur in hospital [34]. It is a health system problem be-
cause, as noted, much research in palliative care has in-
volved the organization and delivery of palliative care
services [35]. It is a health systems problem because qual-
ity improvement techniques, such as rapid cycle change,
have been applied in an effort to improve the quality of
end-of-life care. Finally, it is a health systems problem be-
cause of the need to introduce quality end-of-life care into
the education and accountability of health system manag-
ers and health care professionals.
However, there is a more fundamental sense in which
quality end-of-life care is a health systems problem. As we
have argued, improving quality end-of-life care is a prob-
lem of health information. Information about quality is
recognized as a central health system concern, as exempli-
fied by the report card movement. We have never seen in-
formation on quality end-of-life care on quality report
cards. Why? Just as clinicians once put dying patients in
the room at the end of the hall and never made rounds on
them, health policy makers have kept the issue of quality
end-of-life care outside the mainstream of their concerns.
For example, despite data on mortality, and on other
measures of quality of care, there is no information on
quality indicators for end-of-life care in the statistical ap-
pendices of WHO's World Health Reports. There were also
no measures related to quality end-of-life care among the
health system performance measures in the 2000 World
Health Report.
The lack of knowledge related to the end-of-life experience
represents a health information deficit. It is remarkable
that such a significant element of health care delivery is so
poorly understood. Health systems may not want to be
known as good places to die, since this may counteract the
cure-oriented message underlying much of acute care. Yet
the conditions of the dying are often unacceptable, and
more and more people are calling for change. Even in a
developed nation with universal health care such as Can-
ada, we don't know how 222,000 Canadians who die each
year fare, nor do we know how their end-of-life experience
has affected others. The Canadian Senate, in its 2000 re-
port on quality end-of-life care, recommended that the
Canadian Institute for Health Care Information develop
indicators for quality end-of-life care [36]. To our knowl-
edge this is the first example of a recommendation for a
national information strategy on the problem of quality
end-of-life care, but at the moment it is only a recommen-
dation.
Like for the 15% of people dying in developed countries,
there is only anecdotal evidence about the end-of-life ex-
perience of the 85% dying in developing countries. This
represents a major information deficit and barrier to im-
proved end-of-life care. We will return to this information
deficit in our recommendations.
The epidemiological context of quality end-of-life care
As noted, the vast majority of the world's 56 million
deaths annually occur in developing countries. At the
same time, most research and many of the initiatives on
end-of-life care have been in developed countries. This
gap is important to note since applying strategies and con-
cepts from developed onto developing countries may be
inappropriate simply because of the epidemiological con-
text of death, let alone the cultural differences which we
address in the next section. The context of deaths in devel-
oped and developing countries are different, and context
matters in end-of-life care. For example, the initial model
of palliative care was based on cancer patients, and this
has had a significant influence on the development of pal-
liative care. The majority of deaths in developed countries,
however, are not related to cancer. Concepts and strategies
applicable to the usual slowly declining tempo of cancer
deaths may not be applicable to the sudden reversals of
people with heart disease. This difference in context of
death in developed countries may explain in part why the
initial models of palliative care have unfortunately not
solved the problem of quality end-of-life care in devel-
oped countries. Since the context of deaths between devel-BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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oped and developing countries is also different, these
differences are important to acknowledge and explore in
striving to improve end-of-life care.
Causes of death differ between developed and developing
countries. According to estimates in WHO's World Health
Report 2000, the five leading causes of death in sub-Saha-
ran Africa are HIV/AIDS (2,154,000), acute lower respira-
tory infections (1,073,000), malaria (953,000),
diarrhoeal diseases (765,000), and measles (514,000)
[37]. Over half the deaths in these countries are attributa-
ble to infectious and parasitic diseases. In fact, infectious
diseases are responsible for almost half of mortality in de-
veloping countries throughout the world. And, approxi-
mately half of infectious disease mortality can be
attributed to just three diseases–HIV/AIDS, TB, and malar-
ia. These three diseases cause over 300 million illnesses
and more than 5 million deaths each year [38]. These pat-
terns may change as the annual number of tobacco-relat-
ed deaths is expected to rise dramatically, from three
million to about 10 million by the year 2025 [39,40].
In the countries which make up the lowest mortality stra-
tum in North America (Canada, Cuba and U.S.), the five
leading causes of death are ischemic heart disease
(551,000), cerebrovascular disease (187,000), lung/tra-
chea/bronchus cancers (180,000), chronic obstructive
pulmonary disease (118,000), and lower respiratory in-
fections (101,000). More than 65% of deaths here are at-
tributable to some form of cancer or cardiovascular
disease. Whereas a mere 2% of deaths are attributable to
infectious diseases [41,42].
In the last hundred years and with particular concentra-
tion in recent decades, the west has seen a significant shift
from death occurring from infectious diseases to death oc-
curring from degenerative conditions occurring late in life
[43]. These changes have lengthened both life and the dy-
ing trajectory. In the developing world death is often a
faster process and occurs earlier in life. For example, in Af-
rica, infant mortality is close to 10%, and an average of
151 of every 1,000 children die before age five, according
to World Bank statistics [44]. Although AIDS is an afflic-
tion well known in Western health care, it is a more brisk,
debilitating illness in developing countries [45]. The lived
experience of people in the developed world is that of
death occurring largely in old age as opposed to the devel-
oping world in which a high proportion of preventable
deaths occur in childhood and early adult life.
Examining recent data one may assume that the global
picture for health — and by implication for end-of-life
care — is encouraging. In 1955, the world average of life
expectancy was 48 years; by 1995 it had risen to 65 years.
However, this positive trend masks the fact that improve-
ments are not universal. In 16 countries, life expectancy
declined between 1975–1995 [46]. In much of sub-Saha-
ran Africa, AIDS, in combination with declining econo-
mies and health care delivery systems, is having a
powerful effect on health, the nature and experience of dy-
ing, and life expectancy. In Uganda, for example, AIDS is
the leading cause of death in young adults, and life expect-
ancy between 1995–2000 was 32.7 years [47]. Seven
countries in sub-Saharan Africa now have life expectancies
below 40 years; by 2010, 11 countries are expected to have
life expectancies near 30 years [48].
It is easy to make too much of the differences in causes of
death in developed and developing countries. We do not
want to enter into those debates here. Rather, we simply
want to sound a cautionary note. Strategies to improve
end-of-life care depend on context including the patterns
of death, this context varies around the world, and these
contextual features must be taken into account to enhance
the opportunities for success of any concepts and strate-
gies to improve end-of-life care.
The cultural context of quality end-of-life care
Because culture significantly influences how we see the
world, any effort to understand or improve quality end-
of-life care in the world must be sensitive to cultural con-
siderations. Cultures are much deeper than their tradi-
tions, extending to fundamental differences in modes of
reasoning grounded in the way the world is perceived.
Furthermore, it is known that attitudes toward end-of-life
care is relative to particular cultures, societies, and times
[49]. Often, when people planning or providing health
care and recipients of health care come from different cul-
tural backgrounds, they interact under the influence of
unspoken assumptions that are so different that they pre-
vent effective communication and initiatives may break
down all together [50–52]. Simply applying Western per-
spectives on end-of-life care to developing nations is un-
realistic, and apt to fail.
Although Western culture is diverse, evolving and increas-
ingly views health and illness in a broader context, West-
ern medicine remains largely based on scientific, rational
and objective principles. Ultimately this is as much a cul-
tural construction as any non-Western philosophic or
health-related belief system. Disease is perceived as being
largely under the control of science [53]. Because of the in-
stitutionalization of death, many people may expect med-
ical solutions at the end-of-life. Death is often perceived as
a failure of medical care. Demand for aggressive treatment
at the end-of-life can become extreme and unrealistic. Re-
search in North America shows that 18 per cent of lifetime
costs for medical care are apt to be incurred in the last year
of life [54].BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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The growing concern about death and dying arose in the
1950s and 1960s as science became increasingly ques-
tioned. This concern was coupled with an emerging cul-
tural trend toward planning and controlling major life
events [55], a tendency concentrated in educated groups
[56]. This trend is reflected in the debates about advance
directives and euthanasia.
Some of the early hospices were founded by people with
Christian beliefs, or in religious institutions. Therefore,
some aspects of the palliative care/hospice care movement
are rooted in Christian heritage and have philosophic un-
derpinnings that may be foreign to many people in the de-
veloping world who see the world from a different
philosophic or religious perspective. The direct applica-
tion of traditional hospice/palliative care programs to the
developing world may therefore be problematic.
An important cultural distinction in Western medicine is
that it is assumed that the person experiencing the illness
is the best person to make health-care decisions. However,
many non-Western cultures perceive the family or com-
munity as vital in receiving and disclosing information
necessary to decision making and to the organization of
patient care. Furthermore significant differences exist in
gender roles. Particularly in the developing world, caregiv-
ing has been and continues to be overwhelmingly the re-
sponsibility of women [57]. Although men may also be
caregivers, these roles are not culturally perceived as sig-
nificant aspects of their lives. Unfortunately, because
much discussion and policy formation have been from
male perspectives, the individual and social significance
of female procreative and caregiving roles has often been
ignored. These differences require respect, understanding
and careful cross-cultural consideration.
Many people in developing countries hold profoundly
different views of the nature, cause and meaning of
health, illness, death and dying than those in the devel-
oped world. The concept of explanatory models of illness
reflect the cultural understanding of what illness is, how it
occurs, why it exists and what measures can be taken to
prevent or control it [58]. In Western medicine, the prima-
ry explanatory model of illness focuses on abnormalities
in the structure and function of body organs and systems.
Most non-Western cultures tend to perceive illness in a
much broader and far less tangible manner — for exam-
ple, some Africans may perceive health and disease as sep-
arate entities, influenced by external forces such as
witchcraft, revenge or other social causes [59]. These belief
systems are often referred to as traditional belief systems.
Western culture however is ubiquitous, the vast majority
of explanatory models of illness are now intricately blend-
ed between Western and traditional perspectives.
For many people in developing countries stronger reli-
gious and cultural observances and community support
may ameliorate much of the need or expectation for "spe-
cialized" approaches to end-of-life care. In many societies
in the developing world many people are barely exposed
to other views — traditional beliefs of death being the will
of God or a natural consequence of the cycle of life may
be profoundly comforting and nurture a fatalistic accept-
ance and stoicism toward death. Introducing death as a
"specialized" service — by viewing suffering as a treatable,
medical phenomenon — raises a profound ethical ques-
tions as to whether it in the developing world-would it be
at odds with existing cultural and religious perspectives on
suffering, death and their meaning [60].
The health care infrastructure of some developing coun-
tries may be minimal, and focused on disease prevention.
Discussions of death, in this context, may be shunned as
they are a reminder of the gross inadequacies of the health
care system. As with Western nations effective pain con-
trol is problematic, although the roots of the problem are
different. In developing nations pain control is impeded
by a lack of opioids and a fear of Western style drug prob-
lems, which may greatly limit the use of analgesics.
These cultural considerations lead to the conclusion that
any effort to improve quality of end-of-life care in devel-
oping countries must be carefully tailored, and include
people from developing countries, who will be sensitive
to the cultural context. Bringing end-of-life care into the
main stream may fit well with the worldview of many de-
veloping cultures, as life and death are more often viewed
as integrated [61].
Capacity for end-of-life care in developing countries
We could identify no systematic data about capacity to de-
liver quality end-of-life care in developing countries.
Health care initiatives in the developing world must deal
with inadequate infrastructures, poor administrative sys-
tems, the extreme poverty of many patients, restricted opi-
oid prescribing and minimal educational opportunities
for health care staff [62]. Clearly, these are not the condi-
tions for building specialized programs. Aggressive high-
tech approaches at the end-of-life are not feasible. A fur-
ther impediment to improving end-of-life care in the de-
veloping world is that a majority of health care spending,
both public and private, goes to curative efforts — hospi-
tals in urban areas often account for more than 80% of to-
tal health care costs. Although changing quickly, the
majority of the population in the developing world con-
tinues to live in rural areas [63].
"Grass roots" palliative care initiatives in developing na-
tions such as Zimbabwe and South Africa [64] are fundedBMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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at a very low level and are often left to deal with assisting
social needs which arise out of the effects of extreme pov-
erty exacerbated by illness. Yet there are early encouraging
results from The Foundation for Hospices in Sub-Saharan Af-
rica which has the mandate of helping the existing hospic-
es sustain and expand their programs. Additionally, the
program teaches basics of HIV/AIDS care and prevention.
Family members are instructed in care-giving techniques,
and are also given an essential orientation of how HIV/
AIDS is and is not transmitted [65]. Introduced 9 years
ago, Hospice Uganda, a model palliative care Initiative in
Africa, has been particularly successful [66]. It focuses on
pain relief and cultural diversity and is an integral part of
the nation's health plan. On a global level, St Christo-
pher's Hospice has trained leaders of hospice programs in
37 countries [23]. In addition, the British charity Help the
Hospices has recently set up a forum for hospices and pal-
liative care around the globe [67]. The International Asso-
ciation of Hospice and Palliative Care (IAHPC) is the only
global volunteer organization dedicated to bridging the
gap in palliative care between the developed and develop-
ing world. This volunteer organization observes that the
principles of attention to detail, community care, low cost
interventions, and family education about care, are truly
universal [68]. Unfortunately, at this time these programs
reach only a small minority of people at the end-of-life.
The urban elite of many developing nations are often the
only recipients of Western style palliative care. This group
and the rural masses live in different worlds. In India, and
other developing nations, palliative care for cancer pa-
tients exists often for the privileged and reaches only a mi-
nority of cancer patients [69]. Again, small local initiatives
in the area of pain control have shown encouraging results
[70].
Views of illness and help-seeking behaviour in the devel-
oping world are in rapid transition. A study done in
Northeast Thailand on the experience of villagers dying at
home revealed that biomedical theories of disease coexist-
ed or have been supplanted by traditional beliefs about
illness [71]. When patients involved with the minimal
health care system are diagnosed with terminal diseases
they are quickly sent home to die. Family and community
provided ample psychosocial care — fortunately the de-
veloping world often has three generation families which
are able and willing to care for the dying (although this
may no longer be the case in countries that have been dev-
astated by AIDS). Community and traditional healers,
however, are on their own to consult and provide diagno-
sis, treatment and palliative care.
An excellent example of how the end-of-life can be im-
proved without high-tech solutions is the WHO Cancer
Program [72]. This initiative works with local govern-
ments to establish national cancer control programs (NC-
CP) to address the cancer problem at the country level in
accordance with the epidemiological, social and econom-
ic situations. This comprehensive approach assesses the
cancer burden and defines priority objectives within the
areas of prevention, treatment and palliation. With careful
planning the establishment of NCCP offers the most ra-
tional means to achieve cancer control, even where re-
sources are severely limited.
For example, under the auspices of the WHO Cancer and
Palliative Care Program of Latin America, physicians,
health care workers and government officials met to iden-
tify problems and strategies for the delivery of palliative
care [73]. This meeting led to the regular exchange of
knowledge and ideas. Methods for parenteral hydration
were developed. Several countries found methods for the
low cost production of opiods. The number of groups in-
volved increased to include physicians, psychologists,
nurses, pharmacists, volunteers, pastoral care workers,
governments officials, hospital administrators, pharma-
ceutical companies, and representatives from non-govern-
mental organizations — all focusing on cost-effective
means of improving the end-of-life for palliative patients.
As a result, measurable outcomes have changed dramati-
cally in much of Latin America. The number of patients
treated by palliative care groups has increased more than
10 times in six years. Opioid use has increased and the
cost of drugs has decreased. Faculties of medicine are con-
ducting education in palliative care both at the undergrad-
uate and postgraduate level. National and provincial
governments have developed palliative care policies. Such
approaches have been developed elsewhere in the world
for cancer patients. Therefore, similar interventions can be
developed with a broader mandate for end-of-life care.
An important consideration in planning for improved
end-of-life care in the developing world is that more med-
ical care does not necessarily lead to better health. The
common indicators of medical care — rates of infant mor-
tality, lost days due to illness, and life expectancy — are
shown to be improved by only 10% [74]. This further
demonstrates the need for patient derived indicators for
measuring the quality of end-of-life care.
Improvements in end-of-life care function independently
of the overall economic development of a nation. For ex-
ample, in Latin America Bruera has noted that some coun-
tries (Cuba, Chile and Costa Rica) have well developed
palliative care systems while others (Mexico and Brazil)
did not [75].
Death in the developing world is most often seen as an in-
tegral part of life. Consequently, the Western "specializa-
tion" of death may already be a contributing factor to whyBMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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traditional Western approaches to end-of-life care have
had so little effect in the developing world. Integrating lo-
cal, culturally based perspectives of health, illness and dy-
ing in combination with building national consensus to
changes in policies, and procedures, are apt to have a
greater effect on improving end-of-life care in the develop-
ing world than implementing contemporary Western
medical advances. The issue of strengthening capacity in
end-of-life care is one to which we will return in our rec-
ommendations.
"If the lives of people in developing countries don't matter, 
why should their deaths?"
Before turning to our recommendations, we need to con-
front a thorny philosophical question underlying any ef-
fort to improve end-of-life care in developing countries.
We live in a world where the life expectancy is 80 years
and rising for people in many developed countries, and
40 years and falling for people in many developing coun-
tries. As noted, many of the deaths in developing coun-
tries are preventable. Underlying these inequities in
health are inequities in knowledge and wealth. It is a rea-
sonable challenge to any global effort to improve end-of-
life care to ask, "In such an unjust world, where apparently
the lives of many people in developing countries do not
matter, why should their deaths?" (A less blunt version of
this question would be to ask whether a focus of quality
end-of-life care is justifiable when many of the deaths in
developing countries are preventable.)
We think this is a fair question. Indeed, in our view, the
inequities in global health represent one of the principal
ethical challenges in the world today. However, we think
it is a classical tu quoque error in logic to argue that because
the lives of people in developing countries do not seem to
matter, their deaths should not matter either. This is not
an either/or choice. Both the lives and the deaths of peo-
ple in developing countries should matter, and we should
do something about both. Put another way, even if some-
one must die prematurely because of the injustice of glo-
bal health inequality, it is doubly unjust for that person to
be condemned to an agonizing death racked by preventa-
ble pain. Moreover, by focusing on improving end-of-life
care, itself a significant humanitarian crisis, we may be
laying the groundwork for a more comprehensive, hu-
mane and ethical health care systems in developing coun-
tries.
Summary
How can we improve the quality of end-of-life care in the 
world?
Quality end-of-life care in the world is a large-scale prob-
lem that admits of no simple solutions. However, concep-
tualizing quality end-of-life care as a global public health
and health systems problem, as we have done in this pa-
per, does lead to certain clear conclusions about the sorts
of initiatives that will help to improve this problem.
Recognizing end-of-life as a global public health and health system 
problem
The very construction of end-of-life care as a global public
health and health systems problem is itself a useful contri-
bution because it mainstreams this issue in global public
health and health policy circles. The way we construct so-
cial problems has great influence on how we address
them. Constructing quality end-of-life care as a global
public health and health systems problem, as we have
done in this paper, presents it as a potentially mainstream
concern of public health and health policy makers. This
construction could be reinforced by editors of general
medical journals concerned with global public health and
health systems issues such as NEJM, JAMA, BMJ, Lancet,
and CMAJ. By conceptualizing quality end-of-life care as a
global public health and health systems problem, it also
falls under the scope of WHO's initiatives on health sys-
tem performance, a point to which we will return below.
Capacity strengthening
Capacity strengthening is increasingly recognized as a cru-
cial tool for social change on global public health and
health systems issues. As we have noted, we could find no
systematic data about capacity to deliver quality end-of-
life care in developing countries. The first step therefore
will be an assessment of existing capacity for delivering
end-of-life care in developing countries; information
which could be obtained in part through country specific
case studies described below. The next step will be to
strengthen existing capacity. It is recognized that "bottom
up" approaches to capacity strengthening, with strong
participation from people in developing countries, are
more effective than "top down" approaches led only by
people from developed countries. This will be doubly true
for efforts to improve quality end-of-life care in develop-
ing countries in light of the important cultural considera-
tions in relation to death as outlined above. Both
individual and institutional capacity will need strengthen-
ing. The scope of this capacity strengthening should be
broad. For example, traditional healers may serve as effec-
tive champions of quality end-of-life care in some settings
because they are closely connected with shared values and
community beliefs. Obviously knowing a culture's chief
sources of power, whether it is mythological, social or po-
litical, is essential to the development of effective, well-ac-
cepted health care initiatives. Ultimately, every clinician
caring for dying patients should have clinical competen-
cies that promote quality end-of-life care, and educational
initiatives such as the EPEC project or Ian Anderson Pro-
gram referred to above could be built upon. The Open So-
ciety Institute has made a major impact on capacity for
addressing end-of-life care in the US through its Project onBMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/4
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Death in America (PDIA). It has begun to work in Eastern
Europe. It seems the time might be ripe for a global effort
at strengthening capacity in end-of-life care by creating a
Project on Death in the World (PDIW). We have recently
outlined a vision for capacity strengthening in global
health ethics, and this too should include attention to the
problem of quality end-of-life care [76,77].
Information strategies
The problem of quality end-of-life care is, among other
things, a problem of lack of health information. It seems
difficult to know how to improve quality end-of-life care
without any understanding of what the current level of
quality is, what determines it, and how improvement
could be measured. We have mentioned that no national
health system to our knowledge systematically collects in-
formation on quality end-of-life care of its dying citizens.
This is an obvious first step and one where countries with
well developed health "info-structures," such as Canada,
could make an important contribution to global public
health. In addition, important research could be done to
include questions on quality end-of-life care in existing
survey instruments, such as a health and nutrition house-
hold survey conducted in developing countries. A set of
country-specific case studies would provide useful evi-
dence on which to base any global effort to improve end-
of-life care. Indeed, we will know that the problem of
quality end-of-life care has truly been globalized when the
World Health Organization devotes a World Health Re-
port to end-of-life care, and when quality end-of-life care
indicators are routinely included in WHO's annual indica-
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